nodes	percent_of_prediction	percent_of_DWPC	metapath
Azelaic Acid—Vorinostat—hematologic cancer	0.882	1	CrCtD
Azelaic Acid—TYR—hematopoietic system—hematologic cancer	0.00344	0.333	CbGeAlD
Azelaic Acid—AKR1D1—testis—hematologic cancer	0.00325	0.314	CbGeAlD
Azelaic Acid—TYR—Dopamine metabolism—NQO1—hematologic cancer	0.00272	0.179	CbGpPWpGaD
Azelaic Acid—TYR—blood—hematologic cancer	0.00228	0.221	CbGeAlD
Azelaic Acid—Vorinostat—HDAC11—hematologic cancer	0.00206	0.429	CrCbGaD
Azelaic Acid—TYR—lymph node—hematologic cancer	0.00137	0.132	CbGeAlD
Azelaic Acid—Vorinostat—NCOR1—hematologic cancer	0.00108	0.226	CrCbGaD
Azelaic Acid—Vorinostat—HDAC9—hematologic cancer	0.00101	0.21	CrCbGaD
Azelaic Acid—AKR1D1—Bile acid and bile salt metabolism—ABCC3—hematologic cancer	0.000957	0.063	CbGpPWpGaD
Azelaic Acid—Vorinostat—HDAC2—hematologic cancer	0.000648	0.135	CrCbGaD
Azelaic Acid—AKR1D1—Metapathway biotransformation—EPHX1—hematologic cancer	0.000419	0.0276	CbGpPWpGaD
Azelaic Acid—AKR1D1—Bile acid and bile salt metabolism—ALB—hematologic cancer	0.000305	0.0201	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	0.000284	0.0187	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metapathway biotransformation—GSTO1—hematologic cancer	0.00027	0.0178	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	0.00026	0.0171	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metapathway biotransformation—UGT1A1—hematologic cancer	0.000254	0.0167	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	0.000253	0.0167	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	0.000232	0.0152	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	0.000183	0.0121	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	0.000163	0.0107	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Imatinib—hematologic cancer	0.00015	0.00172	CcSEcCtD
Azelaic Acid—Oedema—Melphalan—hematologic cancer	0.00015	0.00172	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	0.000149	0.00983	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Cladribine—hematologic cancer	0.000148	0.00169	CcSEcCtD
Azelaic Acid—Pain—Chlorambucil—hematologic cancer	0.000147	0.00169	CcSEcCtD
Azelaic Acid—Pruritus—Teniposide—hematologic cancer	0.000146	0.00168	CcSEcCtD
Azelaic Acid—Oedema—Lenalidomide—hematologic cancer	0.000146	0.00167	CcSEcCtD
Azelaic Acid—Rash—Methoxsalen—hematologic cancer	0.000146	0.00167	CcSEcCtD
Azelaic Acid—Dermatitis—Methoxsalen—hematologic cancer	0.000146	0.00167	CcSEcCtD
Azelaic Acid—AKR1D1—Metapathway biotransformation—GSTP1—hematologic cancer	0.000145	0.00956	CbGpPWpGaD
Azelaic Acid—Skin exfoliation—Methotrexate—hematologic cancer	0.000144	0.00165	CcSEcCtD
Azelaic Acid—Pain—Nilotinib—hematologic cancer	0.000144	0.00165	CcSEcCtD
Azelaic Acid—Oedema—Hydroxyurea—hematologic cancer	0.000144	0.00165	CcSEcCtD
Azelaic Acid—Asthma—Triamcinolone—hematologic cancer	0.000144	0.00164	CcSEcCtD
Azelaic Acid—Pain—Imatinib—hematologic cancer	0.000143	0.00164	CcSEcCtD
Azelaic Acid—Erythema—Carmustine—hematologic cancer	0.000143	0.00163	CcSEcCtD
Azelaic Acid—Paraesthesia—Vinblastine—hematologic cancer	0.000142	0.00162	CcSEcCtD
Azelaic Acid—Rash—Mercaptopurine—hematologic cancer	0.000142	0.00162	CcSEcCtD
Azelaic Acid—Dermatitis—Mercaptopurine—hematologic cancer	0.000141	0.00162	CcSEcCtD
Azelaic Acid—Hypersensitivity—Busulfan—hematologic cancer	0.000141	0.00162	CcSEcCtD
Azelaic Acid—Erythema—Alitretinoin—hematologic cancer	0.000141	0.00162	CcSEcCtD
Azelaic Acid—Pain—Cladribine—hematologic cancer	0.000141	0.00161	CcSEcCtD
Azelaic Acid—Dermatitis contact—Epirubicin—hematologic cancer	0.00014	0.0016	CcSEcCtD
Azelaic Acid—Rash—Daunorubicin—hematologic cancer	0.00014	0.0016	CcSEcCtD
Azelaic Acid—Rash—Clofarabine—hematologic cancer	0.00014	0.0016	CcSEcCtD
Azelaic Acid—Erythema—Ifosfamide—hematologic cancer	0.00014	0.0016	CcSEcCtD
Azelaic Acid—Dermatitis—Daunorubicin—hematologic cancer	0.00014	0.0016	CcSEcCtD
Azelaic Acid—Dermatitis—Clofarabine—hematologic cancer	0.00014	0.0016	CcSEcCtD
Azelaic Acid—Rash—Pentostatin—hematologic cancer	0.000139	0.00159	CcSEcCtD
Azelaic Acid—Rash—Anagrelide—hematologic cancer	0.000139	0.00159	CcSEcCtD
Azelaic Acid—Dermatitis—Anagrelide—hematologic cancer	0.000139	0.00159	CcSEcCtD
Azelaic Acid—Dermatitis—Pentostatin—hematologic cancer	0.000139	0.00159	CcSEcCtD
Azelaic Acid—Dry skin—Dexamethasone—hematologic cancer	0.000138	0.00158	CcSEcCtD
Azelaic Acid—Dry skin—Betamethasone—hematologic cancer	0.000138	0.00158	CcSEcCtD
Azelaic Acid—Hypersensitivity—Procarbazine—hematologic cancer	0.000137	0.00157	CcSEcCtD
Azelaic Acid—Pruritus—Busulfan—hematologic cancer	0.000136	0.00155	CcSEcCtD
Azelaic Acid—Pain—Vinblastine—hematologic cancer	0.000135	0.00155	CcSEcCtD
Azelaic Acid—Skin exfoliation—Epirubicin—hematologic cancer	0.000135	0.00155	CcSEcCtD
Azelaic Acid—Paraesthesia—Melphalan—hematologic cancer	0.000135	0.00154	CcSEcCtD
Azelaic Acid—Oedema—Bortezomib—hematologic cancer	0.000134	0.00154	CcSEcCtD
Azelaic Acid—Hypersensitivity—Bexarotene—hematologic cancer	0.000134	0.00154	CcSEcCtD
Azelaic Acid—Hypersensitivity—Dasatinib—hematologic cancer	0.000134	0.00154	CcSEcCtD
Azelaic Acid—Rash—Idarubicin—hematologic cancer	0.000134	0.00154	CcSEcCtD
Azelaic Acid—Dermatitis—Idarubicin—hematologic cancer	0.000134	0.00153	CcSEcCtD
Azelaic Acid—Hypersensitivity—Fludarabine—hematologic cancer	0.000134	0.00153	CcSEcCtD
Azelaic Acid—AKR1D1—Metapathway biotransformation—GSTM1—hematologic cancer	0.000133	0.00878	CbGpPWpGaD
Azelaic Acid—Oedema—Bleomycin—hematologic cancer	0.000133	0.00153	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	0.000133	0.00876	CbGpPWpGaD
Azelaic Acid—Erythema—Mitoxantrone—hematologic cancer	0.000133	0.00152	CcSEcCtD
Azelaic Acid—Pruritus—Procarbazine—hematologic cancer	0.000132	0.00151	CcSEcCtD
Azelaic Acid—Paraesthesia—Lenalidomide—hematologic cancer	0.000131	0.0015	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	0.00013	0.00859	CbGpPWpGaD
Azelaic Acid—Rash—Teniposide—hematologic cancer	0.00013	0.00149	CcSEcCtD
Azelaic Acid—Dermatitis—Teniposide—hematologic cancer	0.00013	0.00149	CcSEcCtD
Azelaic Acid—Dermatitis contact—Doxorubicin—hematologic cancer	0.000129	0.00148	CcSEcCtD
Azelaic Acid—Erythema—Gemcitabine—hematologic cancer	0.000129	0.00148	CcSEcCtD
Azelaic Acid—Pruritus—Dasatinib—hematologic cancer	0.000129	0.00148	CcSEcCtD
Azelaic Acid—Pruritus—Bexarotene—hematologic cancer	0.000129	0.00148	CcSEcCtD
Azelaic Acid—Pruritus—Fludarabine—hematologic cancer	0.000129	0.00147	CcSEcCtD
Azelaic Acid—Pain—Melphalan—hematologic cancer	0.000128	0.00147	CcSEcCtD
Azelaic Acid—Hypersensitivity—Chlorambucil—hematologic cancer	0.000127	0.00145	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—FTCD—hematologic cancer	0.000127	0.00833	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GMPS—hematologic cancer	0.000127	0.00833	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PHYH—hematologic cancer	0.000127	0.00833	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	0.000125	0.00825	CbGpPWpGaD
Azelaic Acid—Skin exfoliation—Doxorubicin—hematologic cancer	0.000125	0.00143	CcSEcCtD
Azelaic Acid—Pain—Lenalidomide—hematologic cancer	0.000125	0.00143	CcSEcCtD
Azelaic Acid—Hypersensitivity—Nilotinib—hematologic cancer	0.000124	0.00142	CcSEcCtD
Azelaic Acid—Hypersensitivity—Imatinib—hematologic cancer	0.000123	0.00141	CcSEcCtD
Azelaic Acid—Pain—Hydroxyurea—hematologic cancer	0.000123	0.00141	CcSEcCtD
Azelaic Acid—Pruritus—Chlorambucil—hematologic cancer	0.000122	0.0014	CcSEcCtD
Azelaic Acid—Hypersensitivity—Cladribine—hematologic cancer	0.000121	0.00139	CcSEcCtD
Azelaic Acid—Oedema—Thalidomide—hematologic cancer	0.000121	0.00139	CcSEcCtD
Azelaic Acid—Rash—Busulfan—hematologic cancer	0.000121	0.00139	CcSEcCtD
Azelaic Acid—Dermatitis—Busulfan—hematologic cancer	0.000121	0.00138	CcSEcCtD
Azelaic Acid—Paraesthesia—Bortezomib—hematologic cancer	0.000121	0.00138	CcSEcCtD
Azelaic Acid—Erythema—Cisplatin—hematologic cancer	0.00012	0.00138	CcSEcCtD
Azelaic Acid—Dry skin—Prednisone—hematologic cancer	0.00012	0.00138	CcSEcCtD
Azelaic Acid—Paraesthesia—Bleomycin—hematologic cancer	0.00012	0.00137	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	0.000119	0.00786	CbGpPWpGaD
Azelaic Acid—Pruritus—Nilotinib—hematologic cancer	0.000119	0.00137	CcSEcCtD
Azelaic Acid—Pruritus—Imatinib—hematologic cancer	0.000118	0.00136	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	0.000118	0.00777	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Vinorelbine—hematologic cancer	0.000118	0.00135	CcSEcCtD
Azelaic Acid—Rash—Procarbazine—hematologic cancer	0.000117	0.00134	CcSEcCtD
Azelaic Acid—Dermatitis—Procarbazine—hematologic cancer	0.000117	0.00134	CcSEcCtD
Azelaic Acid—Pruritus—Cladribine—hematologic cancer	0.000116	0.00133	CcSEcCtD
Azelaic Acid—Oedema—Carmustine—hematologic cancer	0.000116	0.00133	CcSEcCtD
Azelaic Acid—Hypersensitivity—Vinblastine—hematologic cancer	0.000116	0.00133	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	0.000116	0.00766	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—SMPD3—hematologic cancer	0.000116	0.00762	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	0.000115	0.0076	CbGpPWpGaD
Azelaic Acid—Oedema—Alitretinoin—hematologic cancer	0.000115	0.00132	CcSEcCtD
Azelaic Acid—Rash—Bexarotene—hematologic cancer	0.000115	0.00132	CcSEcCtD
Azelaic Acid—Rash—Dasatinib—hematologic cancer	0.000115	0.00132	CcSEcCtD
Azelaic Acid—Pain—Bortezomib—hematologic cancer	0.000115	0.00132	CcSEcCtD
Azelaic Acid—Dermatitis—Bexarotene—hematologic cancer	0.000115	0.00132	CcSEcCtD
Azelaic Acid—Dermatitis—Dasatinib—hematologic cancer	0.000115	0.00132	CcSEcCtD
Azelaic Acid—Rash—Fludarabine—hematologic cancer	0.000115	0.00131	CcSEcCtD
Azelaic Acid—Dermatitis—Fludarabine—hematologic cancer	0.000115	0.00131	CcSEcCtD
Azelaic Acid—Pain—Bleomycin—hematologic cancer	0.000114	0.00131	CcSEcCtD
Azelaic Acid—Oedema—Ifosfamide—hematologic cancer	0.000114	0.00131	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—PHYH—hematologic cancer	0.000113	0.00743	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—FTCD—hematologic cancer	0.000113	0.00743	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—GMPS—hematologic cancer	0.000113	0.00743	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Thiotepa—hematologic cancer	0.000112	0.00129	CcSEcCtD
Azelaic Acid—Pain—Vinorelbine—hematologic cancer	0.000112	0.00129	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	0.000112	0.00735	CbGpPWpGaD
Azelaic Acid—Oedema—Vincristine—hematologic cancer	0.000111	0.00127	CcSEcCtD
Azelaic Acid—Hypersensitivity—Melphalan—hematologic cancer	0.000111	0.00127	CcSEcCtD
Azelaic Acid—Paraesthesia—Thalidomide—hematologic cancer	0.000109	0.00125	CcSEcCtD
Azelaic Acid—Erythema—Prednisolone—hematologic cancer	0.000109	0.00125	CcSEcCtD
Azelaic Acid—Oedema—Irinotecan—hematologic cancer	0.000108	0.00124	CcSEcCtD
Azelaic Acid—Oedema—Mitoxantrone—hematologic cancer	0.000108	0.00124	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	0.000108	0.0071	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Lenalidomide—hematologic cancer	0.000108	0.00123	CcSEcCtD
Azelaic Acid—Pain—Thiotepa—hematologic cancer	0.000107	0.00123	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	0.000106	0.007	CbGpPWpGaD
Azelaic Acid—Pruritus—Melphalan—hematologic cancer	0.000106	0.00122	CcSEcCtD
Azelaic Acid—Rash—Nilotinib—hematologic cancer	0.000106	0.00122	CcSEcCtD
Azelaic Acid—Dermatitis—Nilotinib—hematologic cancer	0.000106	0.00122	CcSEcCtD
Azelaic Acid—Hypersensitivity—Hydroxyurea—hematologic cancer	0.000106	0.00122	CcSEcCtD
Azelaic Acid—Rash—Imatinib—hematologic cancer	0.000106	0.00121	CcSEcCtD
Azelaic Acid—Dermatitis—Imatinib—hematologic cancer	0.000106	0.00121	CcSEcCtD
Azelaic Acid—Oedema—Gemcitabine—hematologic cancer	0.000105	0.00121	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	0.000105	0.00692	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	0.000105	0.00692	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Carmustine—hematologic cancer	0.000104	0.0012	CcSEcCtD
Azelaic Acid—Rash—Cladribine—hematologic cancer	0.000104	0.00119	CcSEcCtD
Azelaic Acid—Dermatitis—Cladribine—hematologic cancer	0.000104	0.00119	CcSEcCtD
Azelaic Acid—Pain—Thalidomide—hematologic cancer	0.000104	0.00119	CcSEcCtD
Azelaic Acid—Paraesthesia—Alitretinoin—hematologic cancer	0.000104	0.00119	CcSEcCtD
Azelaic Acid—Pruritus—Lenalidomide—hematologic cancer	0.000103	0.00118	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—SMPD3—hematologic cancer	0.000103	0.00679	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	0.000103	0.00678	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Ifosfamide—hematologic cancer	0.000102	0.00117	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—DCK—hematologic cancer	0.000101	0.00666	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ASNS—hematologic cancer	0.000101	0.00666	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—B3GAT1—hematologic cancer	0.000101	0.00666	CbGpPWpGaD
Azelaic Acid—Erythema—Triamcinolone—hematologic cancer	0.0001	0.00115	CcSEcCtD
Azelaic Acid—Paraesthesia—Vincristine—hematologic cancer	9.97e-05	0.00114	CcSEcCtD
Azelaic Acid—Pain—Carmustine—hematologic cancer	9.95e-05	0.00114	CcSEcCtD
Azelaic Acid—Hypersensitivity—Bortezomib—hematologic cancer	9.9e-05	0.00113	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	9.89e-05	0.00651	CbGpPWpGaD
Azelaic Acid—Pain—Alitretinoin—hematologic cancer	9.86e-05	0.00113	CcSEcCtD
Azelaic Acid—Oedema—Cisplatin—hematologic cancer	9.82e-05	0.00113	CcSEcCtD
Azelaic Acid—Hypersensitivity—Bleomycin—hematologic cancer	9.82e-05	0.00113	CcSEcCtD
Azelaic Acid—Pain—Ifosfamide—hematologic cancer	9.74e-05	0.00112	CcSEcCtD
Azelaic Acid—Paraesthesia—Irinotecan—hematologic cancer	9.71e-05	0.00111	CcSEcCtD
Azelaic Acid—Paraesthesia—Mitoxantrone—hematologic cancer	9.71e-05	0.00111	CcSEcCtD
Azelaic Acid—Hypersensitivity—Vinorelbine—hematologic cancer	9.66e-05	0.00111	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	9.62e-05	0.00633	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—HDC—hematologic cancer	9.59e-05	0.00631	CbGpPWpGaD
Azelaic Acid—Pruritus—Bortezomib—hematologic cancer	9.5e-05	0.00109	CcSEcCtD
Azelaic Acid—Pain—Vincristine—hematologic cancer	9.5e-05	0.00109	CcSEcCtD
Azelaic Acid—Asthma—Methotrexate—hematologic cancer	9.48e-05	0.00109	CcSEcCtD
Azelaic Acid—Rash—Melphalan—hematologic cancer	9.47e-05	0.00108	CcSEcCtD
Azelaic Acid—Paraesthesia—Gemcitabine—hematologic cancer	9.46e-05	0.00108	CcSEcCtD
Azelaic Acid—Dermatitis—Melphalan—hematologic cancer	9.46e-05	0.00108	CcSEcCtD
Azelaic Acid—Pruritus—Bleomycin—hematologic cancer	9.43e-05	0.00108	CcSEcCtD
Azelaic Acid—Dry skin—Epirubicin—hematologic cancer	9.41e-05	0.00108	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	9.37e-05	0.00617	CbGpPWpGaD
Azelaic Acid—Pruritus—Vinorelbine—hematologic cancer	9.28e-05	0.00106	CcSEcCtD
Azelaic Acid—Pain—Mitoxantrone—hematologic cancer	9.25e-05	0.00106	CcSEcCtD
Azelaic Acid—Pain—Irinotecan—hematologic cancer	9.25e-05	0.00106	CcSEcCtD
Azelaic Acid—Hypersensitivity—Thiotepa—hematologic cancer	9.23e-05	0.00106	CcSEcCtD
Azelaic Acid—Rash—Lenalidomide—hematologic cancer	9.2e-05	0.00105	CcSEcCtD
Azelaic Acid—Dermatitis—Lenalidomide—hematologic cancer	9.2e-05	0.00105	CcSEcCtD
Azelaic Acid—Rash—Hydroxyurea—hematologic cancer	9.08e-05	0.00104	CcSEcCtD
Azelaic Acid—Erythema—Dexamethasone—hematologic cancer	9.07e-05	0.00104	CcSEcCtD
Azelaic Acid—Erythema—Betamethasone—hematologic cancer	9.07e-05	0.00104	CcSEcCtD
Azelaic Acid—Dermatitis—Hydroxyurea—hematologic cancer	9.07e-05	0.00104	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—B3GAT1—hematologic cancer	9.02e-05	0.00594	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—DCK—hematologic cancer	9.02e-05	0.00594	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ASNS—hematologic cancer	9.02e-05	0.00594	CbGpPWpGaD
Azelaic Acid—Pain—Gemcitabine—hematologic cancer	9.01e-05	0.00103	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	8.94e-05	0.00589	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Thalidomide—hematologic cancer	8.93e-05	0.00102	CcSEcCtD
Azelaic Acid—Oedema—Prednisolone—hematologic cancer	8.87e-05	0.00102	CcSEcCtD
Azelaic Acid—Asthma—Epirubicin—hematologic cancer	8.87e-05	0.00102	CcSEcCtD
Azelaic Acid—Pruritus—Thiotepa—hematologic cancer	8.86e-05	0.00102	CcSEcCtD
Azelaic Acid—Paraesthesia—Cisplatin—hematologic cancer	8.82e-05	0.00101	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	8.81e-05	0.0058	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—CDA—hematologic cancer	8.77e-05	0.00577	CbGpPWpGaD
Azelaic Acid—Dry skin—Doxorubicin—hematologic cancer	8.7e-05	0.000997	CcSEcCtD
Azelaic Acid—Photosensitivity reaction—Methotrexate—hematologic cancer	8.65e-05	0.000991	CcSEcCtD
Azelaic Acid—Hypersensitivity—Carmustine—hematologic cancer	8.57e-05	0.000982	CcSEcCtD
Azelaic Acid—Pruritus—Thalidomide—hematologic cancer	8.57e-05	0.000982	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—HDC—hematologic cancer	8.55e-05	0.00563	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Alitretinoin—hematologic cancer	8.49e-05	0.000973	CcSEcCtD
Azelaic Acid—Rash—Bortezomib—hematologic cancer	8.47e-05	0.00097	CcSEcCtD
Azelaic Acid—Dermatitis—Bortezomib—hematologic cancer	8.46e-05	0.00097	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—PC—hematologic cancer	8.44e-05	0.00556	CbGpPWpGaD
Azelaic Acid—Rash—Bleomycin—hematologic cancer	8.4e-05	0.000963	CcSEcCtD
Azelaic Acid—Pain—Cisplatin—hematologic cancer	8.4e-05	0.000962	CcSEcCtD
Azelaic Acid—Dermatitis—Bleomycin—hematologic cancer	8.4e-05	0.000962	CcSEcCtD
Azelaic Acid—Hypersensitivity—Ifosfamide—hematologic cancer	8.39e-05	0.000962	CcSEcCtD
Azelaic Acid—Rash—Vinorelbine—hematologic cancer	8.27e-05	0.000948	CcSEcCtD
Azelaic Acid—Dermatitis—Vinorelbine—hematologic cancer	8.26e-05	0.000947	CcSEcCtD
Azelaic Acid—Asthma—Doxorubicin—hematologic cancer	8.21e-05	0.00094	CcSEcCtD
Azelaic Acid—Hypersensitivity—Vincristine—hematologic cancer	8.18e-05	0.000938	CcSEcCtD
Azelaic Acid—Oedema—Triamcinolone—hematologic cancer	8.16e-05	0.000935	CcSEcCtD
Azelaic Acid—Pruritus—Alitretinoin—hematologic cancer	8.16e-05	0.000934	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—SLC35B2—hematologic cancer	8.15e-05	0.00537	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GBA—hematologic cancer	8.15e-05	0.00537	CbGpPWpGaD
Azelaic Acid—Photosensitivity reaction—Epirubicin—hematologic cancer	8.1e-05	0.000928	CcSEcCtD
Azelaic Acid—Paraesthesia—Etoposide—hematologic cancer	8.08e-05	0.000926	CcSEcCtD
Azelaic Acid—Pruritus—Ifosfamide—hematologic cancer	8.06e-05	0.000924	CcSEcCtD
Azelaic Acid—Hypersensitivity—Irinotecan—hematologic cancer	7.97e-05	0.000913	CcSEcCtD
Azelaic Acid—Hypersensitivity—Mitoxantrone—hematologic cancer	7.97e-05	0.000913	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	7.97e-05	0.00525	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Prednisolone—hematologic cancer	7.97e-05	0.000913	CcSEcCtD
Azelaic Acid—Erythema—Prednisone—hematologic cancer	7.9e-05	0.000905	CcSEcCtD
Azelaic Acid—Rash—Thiotepa—hematologic cancer	7.9e-05	0.000905	CcSEcCtD
Azelaic Acid—Dermatitis—Thiotepa—hematologic cancer	7.89e-05	0.000904	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—CDA—hematologic cancer	7.82e-05	0.00515	CbGpPWpGaD
Azelaic Acid—Pain—Etoposide—hematologic cancer	7.69e-05	0.000882	CcSEcCtD
Azelaic Acid—Rash—Thalidomide—hematologic cancer	7.64e-05	0.000875	CcSEcCtD
Azelaic Acid—Dermatitis—Thalidomide—hematologic cancer	7.63e-05	0.000874	CcSEcCtD
Azelaic Acid—Pain—Prednisolone—hematologic cancer	7.59e-05	0.00087	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—PC—hematologic cancer	7.53e-05	0.00495	CbGpPWpGaD
Azelaic Acid—Photosensitivity reaction—Doxorubicin—hematologic cancer	7.49e-05	0.000858	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—MTAP—hematologic cancer	7.46e-05	0.00491	CbGpPWpGaD
Azelaic Acid—Pruritus—Gemcitabine—hematologic cancer	7.46e-05	0.000854	CcSEcCtD
Azelaic Acid—Oedema—Betamethasone—hematologic cancer	7.41e-05	0.000849	CcSEcCtD
Azelaic Acid—Oedema—Dexamethasone—hematologic cancer	7.41e-05	0.000849	CcSEcCtD
Azelaic Acid—Rash—Carmustine—hematologic cancer	7.34e-05	0.000841	CcSEcCtD
Azelaic Acid—Dermatitis—Carmustine—hematologic cancer	7.33e-05	0.00084	CcSEcCtD
Azelaic Acid—Paraesthesia—Triamcinolone—hematologic cancer	7.33e-05	0.00084	CcSEcCtD
Azelaic Acid—Rash—Alitretinoin—hematologic cancer	7.27e-05	0.000833	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—GBA—hematologic cancer	7.27e-05	0.00478	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—SLC35B2—hematologic cancer	7.27e-05	0.00478	CbGpPWpGaD
Azelaic Acid—Dermatitis—Alitretinoin—hematologic cancer	7.26e-05	0.000832	CcSEcCtD
Azelaic Acid—Hypersensitivity—Cisplatin—hematologic cancer	7.24e-05	0.000829	CcSEcCtD
Azelaic Acid—Rash—Ifosfamide—hematologic cancer	7.18e-05	0.000823	CcSEcCtD
Azelaic Acid—Dermatitis—Ifosfamide—hematologic cancer	7.18e-05	0.000822	CcSEcCtD
Azelaic Acid—Rash—Vincristine—hematologic cancer	7e-05	0.000802	CcSEcCtD
Azelaic Acid—Dermatitis—Vincristine—hematologic cancer	7e-05	0.000802	CcSEcCtD
Azelaic Acid—Pain—Triamcinolone—hematologic cancer	6.98e-05	0.0008	CcSEcCtD
Azelaic Acid—Rash—Mitoxantrone—hematologic cancer	6.82e-05	0.000782	CcSEcCtD
Azelaic Acid—Rash—Irinotecan—hematologic cancer	6.82e-05	0.000782	CcSEcCtD
Azelaic Acid—Dermatitis—Irinotecan—hematologic cancer	6.81e-05	0.000781	CcSEcCtD
Azelaic Acid—Dermatitis—Mitoxantrone—hematologic cancer	6.81e-05	0.000781	CcSEcCtD
Azelaic Acid—Paraesthesia—Dexamethasone—hematologic cancer	6.65e-05	0.000762	CcSEcCtD
Azelaic Acid—Paraesthesia—Betamethasone—hematologic cancer	6.65e-05	0.000762	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—MTAP—hematologic cancer	6.65e-05	0.00438	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—FHL2—hematologic cancer	6.65e-05	0.00438	CbGpPWpGaD
Azelaic Acid—Rash—Gemcitabine—hematologic cancer	6.64e-05	0.000761	CcSEcCtD
Azelaic Acid—Dermatitis—Gemcitabine—hematologic cancer	6.64e-05	0.000761	CcSEcCtD
Azelaic Acid—Hypersensitivity—Etoposide—hematologic cancer	6.63e-05	0.00076	CcSEcCtD
Azelaic Acid—Erythema—Methotrexate—hematologic cancer	6.6e-05	0.000757	CcSEcCtD
Azelaic Acid—Hypersensitivity—Prednisolone—hematologic cancer	6.54e-05	0.000749	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—AGRN—hematologic cancer	6.52e-05	0.00429	CbGpPWpGaD
Azelaic Acid—Oedema—Prednisone—hematologic cancer	6.45e-05	0.000739	CcSEcCtD
Azelaic Acid—Pruritus—Etoposide—hematologic cancer	6.37e-05	0.000729	CcSEcCtD
Azelaic Acid—Pain—Betamethasone—hematologic cancer	6.33e-05	0.000726	CcSEcCtD
Azelaic Acid—Pain—Dexamethasone—hematologic cancer	6.33e-05	0.000726	CcSEcCtD
Azelaic Acid—Rash—Cisplatin—hematologic cancer	6.19e-05	0.00071	CcSEcCtD
Azelaic Acid—Dermatitis—Cisplatin—hematologic cancer	6.19e-05	0.000709	CcSEcCtD
Azelaic Acid—Erythema—Epirubicin—hematologic cancer	6.18e-05	0.000708	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—HMMR—hematologic cancer	6.18e-05	0.00407	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—IDH2—hematologic cancer	6.18e-05	0.00407	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Triamcinolone—hematologic cancer	6.01e-05	0.000689	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—FHL2—hematologic cancer	5.92e-05	0.0039	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.83e-05	0.00384	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—AGRN—hematologic cancer	5.81e-05	0.00383	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ARNTL—hematologic cancer	5.81e-05	0.00383	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Prednisone—hematologic cancer	5.79e-05	0.000664	CcSEcCtD
Azelaic Acid—Pruritus—Triamcinolone—hematologic cancer	5.77e-05	0.000662	CcSEcCtD
Azelaic Acid—Erythema—Doxorubicin—hematologic cancer	5.72e-05	0.000655	CcSEcCtD
Azelaic Acid—Rash—Etoposide—hematologic cancer	5.67e-05	0.00065	CcSEcCtD
Azelaic Acid—Dermatitis—Etoposide—hematologic cancer	5.67e-05	0.000649	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—ACP5—hematologic cancer	5.65e-05	0.00372	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—CA9—hematologic cancer	5.65e-05	0.00372	CbGpPWpGaD
Azelaic Acid—Rash—Prednisolone—hematologic cancer	5.6e-05	0.000641	CcSEcCtD
Azelaic Acid—Dermatitis—Prednisolone—hematologic cancer	5.59e-05	0.000641	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—NCOR2—hematologic cancer	5.58e-05	0.00367	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—IDH2—hematologic cancer	5.51e-05	0.00363	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—HMMR—hematologic cancer	5.51e-05	0.00363	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—IDH1—hematologic cancer	5.31e-05	0.0035	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—TXN—hematologic cancer	5.25e-05	0.00346	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ABCC3—hematologic cancer	5.25e-05	0.00346	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GSTO1—hematologic cancer	5.25e-05	0.00346	CbGpPWpGaD
Azelaic Acid—Pruritus—Betamethasone—hematologic cancer	5.24e-05	0.0006	CcSEcCtD
Azelaic Acid—Pruritus—Dexamethasone—hematologic cancer	5.24e-05	0.0006	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	5.19e-05	0.00342	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ARNTL—hematologic cancer	5.18e-05	0.00341	CbGpPWpGaD
Azelaic Acid—Rash—Triamcinolone—hematologic cancer	5.15e-05	0.00059	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—SPHK1—hematologic cancer	5.14e-05	0.00339	CbGpPWpGaD
Azelaic Acid—Dermatitis—Triamcinolone—hematologic cancer	5.14e-05	0.000589	CcSEcCtD
Azelaic Acid—Oedema—Epirubicin—hematologic cancer	5.04e-05	0.000578	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—CA9—hematologic cancer	5.04e-05	0.00332	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ACP5—hematologic cancer	5.04e-05	0.00332	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—NCOR2—hematologic cancer	4.97e-05	0.00327	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—UGT1A1—hematologic cancer	4.94e-05	0.00325	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Methotrexate—hematologic cancer	4.84e-05	0.000555	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—CRABP1—hematologic cancer	4.81e-05	0.00316	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—SLC22A1—hematologic cancer	4.81e-05	0.00316	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Prednisone—hematologic cancer	4.75e-05	0.000544	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—IDH1—hematologic cancer	4.74e-05	0.00312	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—GSTO1—hematologic cancer	4.68e-05	0.00308	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ALOX5—hematologic cancer	4.68e-05	0.00308	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ABCC3—hematologic cancer	4.68e-05	0.00308	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—TXN—hematologic cancer	4.68e-05	0.00308	CbGpPWpGaD
Azelaic Acid—Rash—Betamethasone—hematologic cancer	4.67e-05	0.000535	CcSEcCtD
Azelaic Acid—Rash—Dexamethasone—hematologic cancer	4.67e-05	0.000535	CcSEcCtD
Azelaic Acid—Oedema—Doxorubicin—hematologic cancer	4.67e-05	0.000535	CcSEcCtD
Azelaic Acid—Dermatitis—Dexamethasone—hematologic cancer	4.66e-05	0.000535	CcSEcCtD
Azelaic Acid—Dermatitis—Betamethasone—hematologic cancer	4.66e-05	0.000535	CcSEcCtD
Azelaic Acid—Pain—Methotrexate—hematologic cancer	4.61e-05	0.000528	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—SPHK1—hematologic cancer	4.58e-05	0.00302	CbGpPWpGaD
Azelaic Acid—Pruritus—Prednisone—hematologic cancer	4.56e-05	0.000523	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—NUP98—hematologic cancer	4.54e-05	0.00299	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Epirubicin—hematologic cancer	4.53e-05	0.000519	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—ADCY7—hematologic cancer	4.4e-05	0.0029	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—UGT1A1—hematologic cancer	4.4e-05	0.0029	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—NCOA3—hematologic cancer	4.4e-05	0.0029	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—NUP214—hematologic cancer	4.37e-05	0.00288	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.33e-05	0.00285	CbGpPWpGaD
Azelaic Acid—Pain—Epirubicin—hematologic cancer	4.31e-05	0.000494	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—SLC22A1—hematologic cancer	4.28e-05	0.00282	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—CRABP1—hematologic cancer	4.28e-05	0.00282	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—MTR—hematologic cancer	4.28e-05	0.00282	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ABCG2—hematologic cancer	4.28e-05	0.00282	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ENO2—hematologic cancer	4.2e-05	0.00277	CbGpPWpGaD
Azelaic Acid—Paraesthesia—Doxorubicin—hematologic cancer	4.19e-05	0.00048	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—ALOX5—hematologic cancer	4.17e-05	0.00275	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GSTT1—hematologic cancer	4.07e-05	0.00268	CbGpPWpGaD
Azelaic Acid—Rash—Prednisone—hematologic cancer	4.07e-05	0.000466	CcSEcCtD
Azelaic Acid—Dermatitis—Prednisone—hematologic cancer	4.06e-05	0.000465	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—NUP98—hematologic cancer	4.04e-05	0.00266	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.01e-05	0.00264	CbGpPWpGaD
Azelaic Acid—Pain—Doxorubicin—hematologic cancer	3.99e-05	0.000457	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—SDC1—hematologic cancer	3.98e-05	0.00262	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Methotrexate—hematologic cancer	3.97e-05	0.000455	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—ADCY7—hematologic cancer	3.92e-05	0.00258	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—NCOA3—hematologic cancer	3.92e-05	0.00258	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—NUP214—hematologic cancer	3.9e-05	0.00257	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	3.86e-05	0.00254	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ABCG2—hematologic cancer	3.82e-05	0.00251	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—MTR—hematologic cancer	3.82e-05	0.00251	CbGpPWpGaD
Azelaic Acid—Pruritus—Methotrexate—hematologic cancer	3.81e-05	0.000437	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.8e-05	0.0025	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.75e-05	0.00247	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ENO2—hematologic cancer	3.74e-05	0.00246	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Epirubicin—hematologic cancer	3.72e-05	0.000426	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—GSTT1—hematologic cancer	3.63e-05	0.00239	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.59e-05	0.00236	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	3.58e-05	0.00235	CbGpPWpGaD
Azelaic Acid—Pruritus—Epirubicin—hematologic cancer	3.57e-05	0.000409	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—SDC1—hematologic cancer	3.55e-05	0.00234	CbGpPWpGaD
Azelaic Acid—Hypersensitivity—Doxorubicin—hematologic cancer	3.44e-05	0.000394	CcSEcCtD
Azelaic Acid—Rash—Methotrexate—hematologic cancer	3.4e-05	0.000389	CcSEcCtD
Azelaic Acid—Dermatitis—Methotrexate—hematologic cancer	3.4e-05	0.000389	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	3.39e-05	0.00223	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—NQO1—hematologic cancer	3.39e-05	0.00223	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—CD44—hematologic cancer	3.39e-05	0.00223	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	3.35e-05	0.0022	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.32e-05	0.00218	CbGpPWpGaD
Azelaic Acid—Pruritus—Doxorubicin—hematologic cancer	3.3e-05	0.000378	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism—CYCS—hematologic cancer	3.2e-05	0.00211	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.2e-05	0.00211	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—HSP90AA1—hematologic cancer	3.18e-05	0.0021	CbGpPWpGaD
Azelaic Acid—Rash—Epirubicin—hematologic cancer	3.18e-05	0.000364	CcSEcCtD
Azelaic Acid—Dermatitis—Epirubicin—hematologic cancer	3.18e-05	0.000364	CcSEcCtD
Azelaic Acid—AKR1D1—Metabolism—NQO1—hematologic cancer	3.02e-05	0.00199	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—CD44—hematologic cancer	3.02e-05	0.00199	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	2.96e-05	0.00195	CbGpPWpGaD
Azelaic Acid—Rash—Doxorubicin—hematologic cancer	2.94e-05	0.000337	CcSEcCtD
Azelaic Acid—Dermatitis—Doxorubicin—hematologic cancer	2.94e-05	0.000337	CcSEcCtD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.86e-05	0.00189	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—CYCS—hematologic cancer	2.86e-05	0.00188	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—HSP90AA1—hematologic cancer	2.84e-05	0.00187	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GSTP1—hematologic cancer	2.82e-05	0.00186	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.73e-05	0.0018	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ABCB1—hematologic cancer	2.67e-05	0.00176	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—GSTM1—hematologic cancer	2.6e-05	0.00171	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—NCOR1—hematologic cancer	2.6e-05	0.00171	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	2.55e-05	0.00168	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—GSTP1—hematologic cancer	2.52e-05	0.00166	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.44e-05	0.0016	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ABCB1—hematologic cancer	2.38e-05	0.00157	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—GSTM1—hematologic cancer	2.31e-05	0.00152	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—NCOR1—hematologic cancer	2.31e-05	0.00152	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—MTHFR—hematologic cancer	2.29e-05	0.00151	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—MTHFR—hematologic cancer	2.04e-05	0.00135	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.02e-05	0.00133	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PIK3CG—hematologic cancer	1.93e-05	0.00127	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.8e-05	0.00119	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—CREBBP—hematologic cancer	1.79e-05	0.00118	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PIK3CG—hematologic cancer	1.72e-05	0.00113	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PIK3CD—hematologic cancer	1.69e-05	0.00112	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—ALB—hematologic cancer	1.67e-05	0.0011	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PIK3R1—hematologic cancer	1.6e-05	0.00105	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—CREBBP—hematologic cancer	1.59e-05	0.00105	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PIK3CD—hematologic cancer	1.51e-05	0.000994	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—ALB—hematologic cancer	1.49e-05	0.000981	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PIK3CB—hematologic cancer	1.48e-05	0.000972	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PIK3R1—hematologic cancer	1.43e-05	0.000939	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PIK3CB—hematologic cancer	1.32e-05	0.000866	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PTEN—hematologic cancer	1.28e-05	0.00084	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—EP300—hematologic cancer	1.22e-05	0.000801	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PTEN—hematologic cancer	1.14e-05	0.000749	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—EP300—hematologic cancer	1.08e-05	0.000714	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—PIK3CA—hematologic cancer	9e-06	0.000593	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—PIK3CA—hematologic cancer	8.02e-06	0.000528	CbGpPWpGaD
Azelaic Acid—SRD5A2—Metabolism—AKT1—hematologic cancer	7.35e-06	0.000484	CbGpPWpGaD
Azelaic Acid—AKR1D1—Metabolism—AKT1—hematologic cancer	6.55e-06	0.000431	CbGpPWpGaD
